Declining Imaging Solutions sales and profit, and the rollout of high-value-added products
First written in FY2020-Q1. 12 of 24 entries say "Advanced", first in FY2023-Q1. Latest entry: 2026-08-06.
No other company in this theme has enough history to compare yet.
- 2026-08-06AdvancedEarnings forecast revision
「The Imaging segment's consolidated net sales were ¥168.8 billion, up 16.2% year on year. Operating income was ¥43.4 billion, up 3.9% year on year.」
The Imaging segment reported higher sales and operating income, with the existing earnings improvement continuing into the first quarter. - FY2026AdvancedAnnual report
「Consolidated sales in this segment were ¥627,087 million, up 15.7% year on year. Operating profit was ¥160,003 million, up 14.9%.」
Imaging sales and operating profit both increased, driven by higher sales of instax and digital cameras, and improvement continued. - FY2026-H1AdvancedAnnual report
「Consolidated sales in this segment were ¥291,525 million, up 13.3% year on year. Operating profit was ¥80,392 million, up 21.5%.」
Imaging sales and operating profit both increased, with continued improvement driven by higher sales of instax and digital cameras. - FY2025AdvancedAnnual report
「Consolidated sales in this segment were ¥541,973 million, up 15.4% year on year. Operating profit was ¥139,214 million, up 36.4%.」
Imaging sales and operating profit both increased, with continued improvement driven by strong performance from instax and digital cameras. - FY2025-H1AdvancedAnnual report
「Consolidated sales in this segment were ¥257,198 million, up 17.4% year on year. Operating profit was ¥66,187 million, up 33.8%.」
Imaging sales rose 17.4% year on year and operating profit rose 33.8%, indicating that the improvement in performance seen through the previous fiscal year continued in the first half. - FY2024AdvancedAnnual report
「Consolidated sales in this segment were ¥469,658 million, up 14.5% year on year. Operating profit was ¥101,947 million, up 39.9%.」
Imaging full-year sales rose 14.5% and operating profit rose 39.9%, indicating continued improvement from the previous fiscal year. - FY2024-Q3AdvancedAnnual report
「Consolidated sales in this segment were ¥368,573 million, up 13.8% year on year. Operating profit was ¥88,878 million, up 41.7%.」
Imaging sales rose 13.8% year on year and operating profit rose 41.7%, indicating continued improvement from the previous fiscal year. - FY2024-Q2AdvancedAnnual report
「Consolidated sales in this segment were ¥219,158 million, up 19.5% year on year. Operating profit was ¥49,360 million, up 85.5%.」
Imaging sales rose 19.5% year on year and operating profit rose 85.5%, indicating continued improvement from the previous fiscal year. - FY2023AdvancedAnnual report
「Consolidated sales in this segment were ¥410,293 million, up 23.1% year on year. Operating profit was ¥72,876 million, up 97.1%.」
Imaging sales rose 23.1% and operating profit rose 97.1%, indicating that performance improved over the previous fiscal year on a full-year basis. - FY2023-Q3AdvancedAnnual report
「Consolidated sales in this segment were ¥323,749 million, up 24.4% year on year. Operating profit was ¥62,732 million, up 80.8%.」
Imaging sales rose 24.4% year on year and operating profit rose 80.8%, indicating continued improvement from the previous fiscal year. - FY2023-Q2AdvancedAnnual report
「Consolidated sales in this segment were ¥183,405 million, up 23.7% year on year. Operating profit was ¥26,615 million, up 114.6%.」
Imaging sales rose 23.7% year on year and operating profit rose 114.6%, indicating continued improvement from the previous fiscal year. - FY2023-Q1AdvancedAnnual report
「Consolidated sales in this segment were ¥82,459 million, up 13.6% year on year. Operating profit was ¥10,542 million, up 31.8%.」
For the Imaging segment, whose performance had deteriorated due to COVID-19 and other factors through the previous fiscal year, first-quarter sales rose 13.6% and operating profit rose 31.8%, indicating continued improvement. - FY2022MitigatedAnnual report
「Consolidated sales in the Imaging segment increased by ¥48,127 million from ¥285,236 million in the previous fiscal year to ¥333,363 million, driven by higher sales in the consumer imaging and professional imaging fields. Operating profit increased by ¥21,386 million from ¥15,591 million in the previous fiscal year to ¥36,977 million.」
The Imaging segment, whose performance had deteriorated due to COVID-19 and other factors, posted full-year increases of 16.9% in sales and 137.2% in operating profit, indicating improved performance. - FY2022-Q3MitigatedAnnual report
「Consolidated sales in this segment were ¥260,165 million, up 19.0% year on year. Operating profit was ¥34,703 million, up 145.6%.」
For the Imaging segment, which had experienced earnings deterioration due to COVID-19 and other factors in the previous fiscal year, sales rose 19.0% and operating profit rose 145.6% for the nine months through the third quarter, indicating continued improvement. - FY2022-Q2MitigatedAnnual report
「Consolidated sales in this segment were ¥113,898 million, down 26.1% year on year.」
Although the Imaging segment declined 26.1% year on year during the relevant period, quarterly sales were ¥148,313 million, up 30.2% year on year, and operating profit was ¥12,401 million, indicating an improvement from the earnings deterioration in the previous fiscal year. - FY2022-Q1MitigatedAnnual report
「Consolidated sales in this segment were ¥72,587 million, up 45.6% year on year. Operating profit was ¥7,998 million.」
Imaging, which had experienced lower sales and an operating loss due to COVID-19 and other factors in the previous fiscal year, posted a 45.6% year-on-year increase in sales and operating profit of ¥7,998 million in the quarter. - FY2021WorsenedAnnual report
「Consolidated sales in the Imaging Solutions segment fell by ¥47,367 million from ¥332,603 million in the previous fiscal year to ¥285,236 million, due to lower sales of color paper and other products, as well as store closures and restrictions on going out caused by COVID-19.」
Imaging Solutions full-year sales fell 14.2% and operating profit fell 37.8%, confirming full-year earnings deterioration caused by COVID-19 and other factors. - FY2021-Q3WorsenedAnnual report
「Consolidated sales in the Imaging Solutions segment were ¥218,646 million, down 17.9% year on year. Operating profit was ¥14,130 million, down 48.5%.」
For the nine months through the third quarter, Imaging Solutions sales fell 17.9% year on year and operating profit fell 48.5%, indicating continued earnings deterioration. The company also reported a recovery in sales of some products during the third-quarter accounting period. - FY2021-Q2WorsenedAnnual report
「Consolidated sales in the Imaging Solutions segment were ¥113,898 million, down 26.1% year on year. Sales of products and services declined across the board due to the spread of COVID-19, which resulted in restrictions on going out in many cities worldwide, store closures, and the voluntary suspension or cancellation of various events. The segment posted an operating loss of ¥2,146 million.」
Imaging Solutions sales fell 26.1% year on year and the segment posted an operating loss of ¥2,146 million. Earnings deterioration caused by COVID-19 continued from the previous quarter. - FY2021-Q1WorsenedAnnual report
「Consolidated sales in the Imaging Solutions segment were ¥49,839 million, down 33.2% year on year. Sales of products and services declined across the board due to the spread of COVID-19, which resulted in restrictions on going out in many cities worldwide, store closures, and the voluntary suspension or cancellation of various events. The segment posted an operating loss of ¥2,972 million.」
Imaging Solutions sales fell 33.2% year on year, resulting in an operating loss of ¥2,972 million. - FY2020WorsenedAnnual report
「Consolidated sales in the Imaging Solutions segment were ¥332,603 million, down 14.0% year on year. Operating profit was ¥25,076 million, down 51.0%.」
Imaging Solutions full-year sales fell 14.0% and operating profit fell 51.0% due to the impact of COVID-19 and other factors, confirming full-year earnings deterioration. - FY2020-Q3WorsenedAnnual report
「① Consolidated sales in the Imaging Solutions segment were ¥266,164 million, down 12.4% year on year. Operating profit was ¥27,431 million, down 42.8%.」
For the nine months through the third quarter, Imaging Solutions sales fell 12.4% year on year and operating profit fell 42.8%, indicating continued earnings deterioration. - FY2020-Q2WorsenedAnnual report
「Consolidated sales in the Imaging Solutions segment were ¥154,070 million, down 12.4% year on year. Operating profit was ¥10,144 million, down 53.0%.」
Imaging Solutions sales fell 12.4% year on year and operating profit fell 53.0%, indicating that earnings deterioration continued after the first quarter. - FY2020-Q1First statedAnnual report
「Consolidated sales in the Imaging Solutions segment were ¥74,636 million, down 15.1% year on year. Operating profit was ¥4,495 million, down 63.2%.」
While Imaging Solutions sales and operating profit declined year on year in the first quarter, the company continued rolling out new products including the instax mini LiPlay, GFX100 and PROJECTOR Z5000.